리브스메드

491000KOSDAQ

44.1 / 100

Reference Date: 2026-09-08

Financial Score15.0 / 40

News Sentiment17.1 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 26.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Livsmed develops, manufactures, and sells laparoscopic surgical instruments for minimally invasive surgery, leveraging its proprietary 90° multi-joint technology to offer products like ArtiSential and ArtiSeal. The company has obtained major international certifications and aims to provide comprehensive solutions in the global minimally invasive surgery market.

Number of Employees

334people

Average Salary

44.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

4.71Industry Average 1.200.0Point

3.9x industry avg (risky)

ROE

-20.75Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

4.02Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 3.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

0.0 / 4

Detailed News Sentiment

6 totalPositive 3Neutral 2Negative 1Average Sentiment Score 68.3

Neutral
코스닥 기술특례상장 21년 만에 300곳 돌파
기술특례상장 기업 수가 코스닥에서 300개를 돌파했으나, 리브스메드(491000)에 직접적인 영향은 미미함.
Positive
'AI 풀스택' 엘리스그룹, 코스닥 상장예비심사 승인…조단위 대어 등....
엘리스그룹의 코스닥 상장 예비심사 승인으로 AI 분야 기업의 성장 기대감이 높아져 리브스메드 관련 긍정적 영향 예상.
Positive
LB인베스트, 성과보수가 관리보수 넘었다…임원 평균 보수 4억
LB인베스트의 상반기 성과보수가 관리보수를 초과함으로써 경영진의 성과에 대한 보상이 강화되어 긍정적인 신호를 보냈다.

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 33,750Won52-week high 91,30052-week low 30,100

1-month return0.0Point

1m -26.95% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14